Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer
Recruiting
N/A
Interventional Study
Sentinel Lymph Node
Ovarian Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Female
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 100 (estimated)
- Sponsor
- Istanbul University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing it to the results obtained from systematic lymphadenectomy, each performed in participants with a suspicious adnexal mass for early-stage ovarian cancer.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Must have a suspicious adnexal mass for early stage ovarian cancer
Must be medically and surgically fit enough to perform SLNB and complete the systematic lymphadenectomy.
\-
Exclusion Criteria:
Ovarian mass with low probability for early stage ovarian cancer.
Medical or su…
Contacts